BioSpace News Archive

Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, today announces that it has entered into definitive agreements with the company’s largest investor and other existing investors, for the purchase and sale of 3,323,616 shares of Petros Pharmaceuticals’ common stock, at a purchase price of $1.715 per share, in a registered direct offering.

Tizona Therapeutics, Inc., a privately held, clinical-stage company developing first-in-class cancer immunotherapies, announced today that its lead investigational therapy, TTX-080, a novel antibody targeting HLA-G, has advanced to Phase 1b.

bioAffinity Technologies today announced that Xavier T. Reveles, MS, CG, has been promoted to Vice President of Operations.

Imec and miDiagnostics announce that they have signed a non-exclusive licensing agreement for imec’s patented technology whereby aerosols and droplets from exhaled breath are captured for screening for viral RNA through miDiagnostics ultrafast PCR technology.

CareBand was awarded the National Institute of Aging (NIA) Phase I Small Business Innovation Research (SBIR) funding to investigate the use of technology to monitor and measure engagement of older adults living in assisted living facilities (ALF) with Alzheimer’s disease and related dementias (ADRD).

Hoag Memorial Hospital Presbyterian today announced that it has enrolled its first two patients in a clinical study evaluating “Natural Killer,” or NK, cell therapy in women with triple-negative breast cancer.

Adjuvant Verzenio in combination with endocrine therapy (ET) continued to demonstrate a significant improvement in reducing the risk of recurrence in patients with HR+ HER2-, node-positive, high risk early breast cancer

Meridian Bioscience, Inc. will report fourth quarter and full year 2021 financial results Friday, November 12, 2021 .

Culture Biosciences, a company enabling biotech firms to develop and scale manufacturing processes in the cloud, announced a Series B financing of $80 million led by Northpond Ventures. Synthesis Capital also participated in the round.

Pharmapack Europe recognizes excellence and innovation in connected devices, wearables, packaging, sustainability, eco-design, patient-centric design, and animal health.